Costa Lab

Research focus

ERC Starting Grant · 2023

Optimize risk prediction after myocardial infarction through artificial intelligence and multidimensional evaluation

Myocardial infarction (MI) is a leading cause of death worldwide. After MI, long-term antithrombotic therapy is crucial to prevent recurrent events, but increases bleeding, that also impacts morbidity and mortality. Giving these competing risks prediction tools to forecast ischemic and bleeding are of paramount importance to inform clinical decisions, but their current precision is limited. Improve events prediction, by discovering novel and innovative markers of risk would have a tremendous impact on therapeutic decisions and patients’ outcome. I hypothesize that using innovative multidimensional information from wearable devices, biomarkers, behavioural patterns and non-invasive imaging,…

From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.